Similarly, gemcitabine is another candidate drug in the asthma-COPD and its intranasal administration significantly reduces viruses and the inflammation of lungs and the anti-inflammatory cytokines including TNF-α and IL-1b. This evidence concerns the gene IL1B and chronic obstructive pulmonary disease.